KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Treasury Shares (2018 - 2025)

Historic Treasury Shares for ClearPoint Neuro (CLPT) over the last 3 years, with Q3 2013 value amounting to $1.7 million.

  • ClearPoint Neuro's Treasury Shares changed 0.0% to $1.7 million in Q3 2013 from the same period last year, while for Sep 2013 it was $1.7 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.7 million for FY2012, which is 0.0% changed from last year.
  • As of Q3 2025, ClearPoint Neuro's Treasury Shares stood at $1.7 million, which was down 158.28% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, ClearPoint Neuro's Treasury Shares ranged from a high of $1.9 million in Q1 2021 and a low of $654179.0 during Q1 2022
  • For the 5-year period, ClearPoint Neuro's Treasury Shares averaged around $1.1 million, with its median value being $768139.0 (2023).
  • Examining YoY changes over the last 5 years, ClearPoint Neuro's Treasury Shares showed a top increase of 0.0% in 2012 and a maximum decrease of 0.0% in 2012.
  • Over the past 3 years, ClearPoint Neuro's Treasury Shares (Quarter) stood at $1.7 million in 2011, then changed by 0.0% to $1.7 million in 2012, then changed by 0.0% to $1.7 million in 2013.
  • Its last three reported values are $1.7 million in Q3 2013, $1.7 million for Q2 2013, and $1.7 million during Q1 2013.